BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 17167139)

  • 1. Medical progress: Acromegaly.
    Melmed S
    N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone-receptor antagonist pegvisomant].
    Herrmann BL; Strasburger CJ
    Dtsch Med Wochenschr; 2004 Oct; 129(44):2356-8. PubMed ID: 15497105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Optimization of the medical treatment for acromegaly].
    Díez JJ; Iglesias P
    Med Clin (Barc); 2013 Apr; 140(8):360-5. PubMed ID: 23103101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
    Cordido F; García Arnés JA; Marazuela Aspiroz M; Torres Vela E;
    Endocrinol Nutr; 2013 Oct; 60(8):457.e1-457.e15. PubMed ID: 23660006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of acromegaly in Spain].
    Sesmilo G
    Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contemporary options and perspectives in the treatment of acromegaly].
    Marek J
    Cas Lek Cesk; 2014; 153(3):131-6. PubMed ID: 24968290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
    Sesmilo G; Webb SM;
    Endocrinol Nutr; 2010 Feb; 57(2):39-42. PubMed ID: 20189894
    [No Abstract]   [Full Text] [Related]  

  • 9. Pegvisomant: Balance after 10 years.
    Bernabeu I; Marazuela M
    Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
    [No Abstract]   [Full Text] [Related]  

  • 10. Current pharmacotherapy for acromegaly: a review.
    Biermasz NR; Romijn JA; Pereira AM; Roelfsema F
    Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic management of acromegaly].
    Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
    Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of carbohydrate metabolism in acromegaly].
    Biagetti B; Obiols G; Valladares S; Arnez L; Dalama B; Mesa J
    Med Clin (Barc); 2013 Nov; 141(10):442-6. PubMed ID: 24012444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly.
    Cook DM; Ezzat S; Katznelson L; Kleinberg DL; Laws ER; Nippoldt TB; Swearingen B; Vance ML;
    Endocr Pract; 2004; 10(3):213-25. PubMed ID: 15382339
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
    van der Lely AJ; Muller A; Janssen JA; Davis RJ; Zib KA; Scarlett JA; Lamberts SW
    J Clin Endocrinol Metab; 2001 Feb; 86(2):478-81. PubMed ID: 11157994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer options in the management of acromegaly.
    Burt MG; Ho KK
    Intern Med J; 2006 Jul; 36(7):437-44. PubMed ID: 16780450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of current and emerging treatment options in acromegaly.
    Muhammad A; van der Lely AJ; Neggers SJ
    Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus on the change of criteria for cure of acromegaly during the last decade].
    Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
    Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.